Skip to content

DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease

DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03462277
Enrollment
200
Registered
2018-03-12
Start date
2018-01-01
Completion date
2018-10-01
Last updated
2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Keywords

methylation, hydroxymethylation, atherosclerosis, coronary heart disease

Brief summary

The purpose of this trial is to investigate the relationship between DNA methylation and hydroxymethylation and the expression of DNMTs, TET family gene and the degree of coronary heart disease.

Detailed description

1. To determine the levels of DNA methylation and hydroxymethylation with coronary heart disease. 2. To investigate the relationship between DNA methylation and hydroxymethylation and the degree of coronary atherosclerosis.

Interventions

None listed

Sponsors

Chongqing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Male and Female. Patients older than 65 years old who are willing to participate in the study. CHD patients was defined as at least one lesion in a coronary artery or branches in coronary angiograms. Control group was defined as people with negative findings in coronary angiograms.

Exclusion criteria

Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases, or any other malignancy. Patients with a history of cardiomyopathy. Pregnant women. Severe hepatic dysfunction or End-stage renal failure. Uncontrolled hypertension.

Design outcomes

Primary

MeasureTime frameDescription
DNA Methylation and Hydroxymethylation Levels1 monthCollection of blood samples and measuring the samples by PCR and ELISA

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026